Intensive insulin therapy in pregnancy: Strategies for successful implementation in pregestational diabetes mellitus

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 2, 2007, Pages 125-132

  Bernasko, James ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Diabetes in pregnancy; Insulin therapy in pregnancy

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; METFORMIN; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT;

CONTRACEPTION; DIET THERAPY; DISEASE DURATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EXERCISE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; KETONURIA; MATERNAL CARE; MATERNAL MORBIDITY; MORBIDITY; MORTALITY; PATIENT CARE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; PRENATAL CARE;

ADMINISTRATION, CUTANEOUS; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL CARE;

EID: 34248523405     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050601144727     Document Type: Review

References (47)

1. American diabetes Association; 2005. Available at: http://www.diabetes. org (accessed January 2007).
2. The Diabetic Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
3. The United Kingdom Prospective Diabetes Study Research Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
4. Ray J, O'Brien T, Chan W. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. Q J Med 2001;94:435-444.
5. Janz N, Herman W, Becker M, Charron-Prochownik D, Shayna V, Lesnick T, Jacober S, Fachnie J, Kruger D, Sanfield J, Rosenblatt S, Lorenz R. Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes Care 1995;18:157-165.
6. Holing E, Beyer C, Brown Z, Connell F. Why don't women with diabetes plan their pregnancies. Diabetes Care 1998;21:889-895.
7. Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003;26:2990-2993.
8. Petersen K, Skouby S, Vedel P, Haaber A. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism. Diabetes Care 1995;18:800-802.
9. Rogovskaya S, Rivera R, Grimes D, Chen P-L, Pierre-Louis B, Prilepskaya V, Kulakov V. Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: A randomized trial. Obstet Gynecol 2005;105:811-815.
10. Jovanovic-Peterson L, Peterson CM. Nutritional management of the obese gestational diabetic pregnant woman. J Am Coll Nutr 1992;11:246-250.
11. Major CA, Henry MJ, De Veciana M, Morgan MA. The effects of carbohydrate restriction on patients with gestational diabetes. Obstet Gynecol 1998;91:600-604.
12. Kalkhoff RK, Kissebah AH, Kim H-J. Carbohydrate and lipid metabolism during normal pregnancy: Relationship to gestational hormone action. Semin Perinatol 1978;12:291-295.
13. Kalkhoff RK, Richardson BL, Beck P. Relative effects of pregnancy, human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects. Diabetes 1969;18:153-163.
14. Samaan N, Yen SC, Gonzalez D, Pearson OH. Metabolic effects of placental lactogen (HPL) in man. J Clin Endocrinol Metab 1968;28:485-491.
15. Burke CW, Roulet F. Increased exposure of tissues to cortisol in late pregnancy. Br Med J 1970;1:657-659.
16. Gustafson AB, Banasiak MF, Kalkhoff RK, Hagen TC, Kim H-J. Correlation of hyperprolactinemia with altered plasma insulin and glucagon: Similarity to effects of late pregnancy. J Clin Endocrinol Metab 1980;51:242-246.
17. Rudolf M, Coustan D, Sherwin R, Bates S, Felig P, Genel M, Tamborlane W. Efficacy of the insulin pump in the home treatment of pregnant diabetics. Diabetes 1981;30:891-895.
18. Kitzmiller J, Younger D, Hare J, Phillipe M, Vignati L, Fargnoli B, Grause A. Continuous subcutaneous insulin therapy during early pregnancy. Obstet Gynecol 1985;66:606-611.
19. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. A meta-analysis. Diabetes Care 2003;26:1079-1087.
20. Chase HP, Saib SZ, Mackenzie T, Hansen MM, Garg SK. Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with type 1 diabetes. Diabet Med 2002;19:317-321.
21. Lepore G, Dodesini A, Nosari I, Trevisan R. Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment. Diabetes Care 2003;26:1321-1322.
22. Simmons D, Thompson CF, Conroy C, Scott DJ. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001;24:2078-2082.
23. Bode BW. Pumping protocol. A physician's guide to insulin pump therapy initiation. Minimed Inc. Publication; 1997.
24. Heinemann L, Weyer C, Rauhaus M, Heinrichs S, Heise T. Variability of the metabolic effect of soluble insulin and the rapid acting insulin analog insulin aspart. Diabetes Care 1998;21:1910-1914.
25. Anderson J, Brunelle R, Koivisto V, Pfutzner A, Trautmann M, Vignati L, DiMarchi R, and the Multicenter Insulin Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997;46:265-270.
26. Zinman B, Tildesley H, Chiasson J-L, Tsui E, Strack T. Insulin lispro in CSII. Diabetes 1997;46:440-443.
27. Brunelle R, Llewelyn J, Anderson J, Gale E, Koivisto V. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998;21:1726-1731.
28. Homko C, Deluzio A, Jimenez C, Kolaczynski J, Boden G. Comparison of insulin aspart and lispro. Pharmacokinetic and metabolic effects. Diabetes Care 2003;26:2027-2031.
29. Hedman C, Lindstrom T, Arnquist H. Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes. Diabetes Care 2001;24:1120-1121.
30. Boskovic R, Feig D, Derewlany L, Knie B, Portnoi G, Koren G. Transfer of insulin lispro across the human placenta. In vitro perfusion studies. Diabetes Care 2003;26:1390-1394.
31. Ben-Haroush A, Yogev Y, Chen R, Rosenn B, Hod M, Langer O. The postprandial glucose profile in diabetic pregnancy. Am J Obstet Gynecol 2004;191:576-581.
32. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995;18:440-447.
33. Miller E, Hare J, Cloherty J, Dunn P, Gleason R, Soeldner S, Kitzmiller J. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331-1334.
34. Ylinen K, Aula P, Stenman U-H, Kesaniemi-Kuokkanen T, Teramo K. Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J 1984;289:345-346.
35. Rosenn B, Miodovnik M, Combs C, Khoury J, Siddiqi T. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994;84:515-520.
36. Reece E, Homko C, Wu Y-K. Multifactorial basis of the syndrome of diabetic embyropathy. Teratology 1997;54:171-182.
37. Derr R, Garrett E, Stacy G, Saudek C. Is HbA1c affected by glycemic instability? Diabetes Care 2003;26:2728-2733.
38. Reiher H, Fuhrmann K, Noack S, Woltanski K-P, Jutzi E, Dorsche H, Hahn H-J. Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 1983;6:446-451.
39. Raychaudhauri K, Maresh J. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 2000;95:190-194.
40. Gold A, Reilly R, Little J, Walker J. The effect of glycemic control in the preconception period and early pregnancy on birth weight in women with IDDM. Diabetes Care 1998;21:535-538.
41. Rey E, Attie C, Bonin A. The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 1999;181:202-206.
42. Jovanovic-Peterson L, Peterson C, Reed G, Metzger B, Mills J, Knopp R, Aarons J, and the National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 1991;164:103-111.
43. Combs C, Gunderson E, Kitzmiller J, Gavin L, Main E. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care 1992;15:1251-1257.
44. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes control and complications trial. Diabetes 1997;46:271-286.
45. Kimmerle R, Heinemann L, Delecki A, Berger M. Severe hypoglycemia: Incidence and predisposing factors in 85 pregnancies of type 1 diabetic women. Diabetes Care 1992;15:1034-1037.
46. Rosenn B, Miodovnik M, Holcberg, Khoury J, Siddiqi T. Hypoglycemia: The price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-422.
47. Lauenborg J, Mathiesen E, Ovesen P, Westergaard J, Ekbom P, Molsted-Pedersen L, Damm P. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care 2003;26:1385-1389.